Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress

Roche today announced that new results from a number of studies across 18 approved and investigational medicines will be presented during the European Society for Medical Oncology (ESMO) Congress from 8-12 September in Madrid, Spain.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news